Recent studies have confirmed that the CRC cell-derived exosome HSPC111 promotes CRC cell migration by reprogramming lipidomic metabolism in CAFs, suggesting that HSPC111 has the tendency to be a potential therapeutic target for the prevention of CRC cell metastasis (144, 145). This evidence concerns the gene NOP16 and colorectal carcinoma.